U.S. sends experimental antibody, antiviral drug to Uganda for Ebola outbreak
October 19, 2022 The United States sent Gilead Sciences’ remdesivir and Mapp Biopharmaceutical Inc’s experimental Ebola antibody drug MBP134 to Uganda last week to help safeguard healthcare workers responding to…
Ebola: New trial drugs will “undoubtedly save lives”, boost survival
Scientists are a step closer to being able to cure the deadly Ebola hemorrhagic fever after two experimental drugs showed survival rates of as much as 90% in a clinical…